@article{7e24bd680e994f12ab7d38855e7565de,
title = "Editorial: combination immunosuppressive therapy to treat Crohn{\textquoteright}s disease – ready for all age groups? Authors' reply",
author = "Siddharth Singh and Vipul Jairath and Stitt, {L. W.} and G. Zou and R. Khanna and Dulai, {P. S.} and Sandborn, {W. J.} and Feagan, {B. G.}",
note = "Funding Information: Declaration of personal interests: Siddharth Singh: Research support from Pfizer and AbbVie, consulting fees from AbbVie, outside the submitted work; Vipul Jairath: Consulting fees from AbbVie, Eli Lilly, GlaxoSmithKline, Arena pharmaceuticals, Genetech, Pendopharm, Sandoz, Merck, Takeda, Janssen, Robarts Clinical Trials, Topivert, Celltrion; speaker's fees from Takeda, Janssen, Shire, Ferring, Abbvie, Pfizer. Funding Information: Research reported in this publication was supported by the American College of Gastroenterology Junior Faculty Development Award #144271, Crohn's and Colitis Foundation Career Development Award #404614, and the National Institute of Diabetes and Digestive and Kidney Diseases K23DK117058 to Siddharth Singh. The content",
year = "2019",
month = jun,
doi = "10.1111/apt.15283",
language = "English (US)",
volume = "49",
pages = "1529",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell",
number = "12",
}